Jose E. Manautou
Professor & Department Head/Pharmaceutical Science
Storrs Mansfield
Are you Jose E. Manautou?
How to update your information.
Scholarly Contributions
186 Scholarly Contributions
Faculty expectations and their management: The UConn school of pharmacy experience
2024
Research Type: Poster/Presentation
Multidrug Resistance Protein-4 (Mrp4) at the Intersection of the Liver-Adipose Tissue Axis”, Belgrade, Serbia, May 30, 2023 (plenary talk)
2023
Research Type: Poster/Presentation
La proteina asociada a resistencia a multiples farmacos tipo 4 (ABCC4/MRP4) se perfila como un nuevo determinante genetico del la enfermedad de higado graso no alcoholico (NAFLD)
2023
Research Type: Poster/Presentation
The beauty of toxicology: When a drug-induced liver injury project becomes a metabolic syndrome, adiposity and diabetes line of investigation
2023
Research Type: Poster/Presentation
La proteína asociada a resistencia a múltiples fármacos tipo 4 (ABCC4/MRP4), además de ser un modulador de la toxicidad de fármacos, es un factor determinante en el desarrollo de la enfermedad de hígado graso no alcohólico.
2023
Research Type: Poster/Presentation
Uncovering new functions of ABC transporter Multidrug resistance protein 4 (MRP4/ABCC4) beyond its well-documented in drug efflux: The link between MRP4 and metabolic syndrome”, Guangzhou, China, November 11, 2023.
2023
Research Type: Poster/Presentation
Safety evaluation of chemicals and drugs regarding their liver toxicity
2022
Research Type: Poster/Presentation
Closing Talk of the Society of Toxicology Undergraduate Educational Program: “Mentoring and Inspiring the Next Generation of Toxicologists: A commitment at a Global Scale”
2022
Research Type: Poster/Presentation
Hepatic Multidrug Resistance Protein 4 (Mrp4): Its Journey through Drug-Induced Liver Injury, Compensatory Hepatocellular Proliferation, Hepatic Steatosis and Metabolic Syndrome
2022
Research Type: Poster/Presentation
Multidrug Resistance Protein-4 (Mrp4): A New Member in the Constellation of Factors Contributing to Non-alcoholic Fatty Liver Disease and Metabolic Syndrome
2022
Research Type: Poster/Presentation
Disruption of Multidrug Resistance Protein 4 (ABCC4) Functionality Raises the Risk of Hepatic Steatosis, Adiposity and Metabolic Syndrome
2022
Research Type: Poster/Presentation
Functional characterization of multidrug resistance protein 4 (Abcc4) in the development of hepatic steatosis during compensatory hepatocellular proliferation
2021
Research Type: Poster/Presentation
Liver Regeneration Following Partial Hepatectomy and the Influence of Drug Transporter Function on the Morphology of the Regained Tissue Mass
2021
Research Type: Poster/Presentation
Symposium entitled Recent Advances in Liver Disease: from Non-Alcoholic Fatty Liver Disease (NAFLD) to Fibrosis (José Manautou, Symposium Chair and Speaker). Presentation: “Impact of Multidrug Resistance Protein 4 (Mrp4) Function on Hepatic Lipid. Virtual Congress
2021
Research Type: Poster/Presentation